Journal of Allergy and Clinical Immunology-In Practice

Article	Citations
Telemedicine in the Era of COVID-19	416
mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach	314
COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic	223
A Consensus Approach to the Primary Prevention of Food Allergy Through Nutrition: Guidance from the American Academy of Allergy, Asthma, and Immunology; American College of Allergy, Asthma, and Immuno	159
US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema	153
Polyethylene Glycol–Induced Systemic Allergic Reactions (Anaphylaxis)	147
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach	145
Chronic Rhinosinusitis with Nasal Polyps and Asthma	144
Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic	139
Global Trends in Anaphylaxis Epidemiology and Clinical Implications	133
Exercise and Fitness in the Age of Social Distancing During the COVID-19 Pandemic	128
Risk Communication During COVID-19	126
Clinician Wellness During the COVID-19 Pandemic: Extraordinary Times and Unusual Challenges for the Allergist/Immunologist	125
Initial effects of the COVID-19 pandemic on pediatric asthma emergency department utilization	122
Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden	108
Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness	107
Prevalence of Food Sensitization and Food Allergy in Children Across Europe	107
Prevalence of Comorbid Asthma and Related Outcomes in COVID-19: A Systematic Review and Meta-Analysis	101
First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing	100
Pediatric Asthma Health Care Utilization, Viral Testing, and Air Pollution Changes During the COVID-19 Pandemic	99
Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs	98
Long-Term Therapy Response to Anti–IL-5 Biologics in Severe Asthma—A Real-Life Evaluation	97
Asthma prolongs intubation in COVID-19	96
Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients	94
Food Allergy from Infancy Through Adulthood	91

Anti-PEG IgE in anaphylaxis associated with polyethylene glycol	82
The Impact of Social Determinants of Health on Children with Asthma	75
Benralizumab as a Steroid-Sparing Treatment Option in Eosinophilic Granulomatosis with Polyangiitis	75
Artificial Intelligence/Machine Learning in Respiratory Medicine and Potential Role in Asthma and COPD Diagnosis	75
The Challenges and Opportunities for Shared Decision Making Highlighted by COVID-19	75
Temporal trends in prevalence of food allergy in Canada	74
Bidirectional Association Between GERD and Asthma: Two Longitudinal Follow-Up Studies Using a National Sample Cohort	73
SARS-CoV-2 Pneumonia in Hospitalized Asthmatic Patients Did Not Induce Severe Exacerbation	72
Hereditary Alpha-Tryptasemia: UK Prevalence and Variability in Disease Expression	69
Improving Diagnostic Accuracy in Food Allergy	69
Clinical Relevance of Cross-Reactivity in Food Allergy	69
Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis	68
Endophenotypic Variations of Atopic Dermatitis by Age, Race, and Ethnicity	68
Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma	67
Rapid recovery of a SARS-CoV-2–infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma	66
Defining a Severe Asthma Super-Responder: Findings from a Delphi Process	66
Biologics for Treatment of Atopic Dermatitis: Current Status and Future Prospect	65
Phenotypes of Chronic Rhinosinusitis	65
Systematic Review of Digital Interventions for Pediatric Asthma Management	64
Clinical outcomes and features of COVID-19 in patients with primary immunodeficiencies in New York City	63
Health-Related Quality of Life in Common Variable Immunodeficiency Italian Patients Switched to Remote Assistance During the COVID-19 Pandemic	61
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes	60
Biologics for the Use in Chronic Spontaneous Urticaria: When and Which	60
Endotypes of Chronic Rhinosinusitis with Nasal Polyps: Pathology and Possible Therapeutic Implications	60
Real-World Effectiveness of Omalizumab in Severe Allergic Asthma: A Meta-Analysis of Observational Studies	60
Emerging Causes of Drug-Induced Anaphylaxis: A Review of Anaphylaxis-Associated Reports in the FDA Adverse Event Reporting System (FAERS)	58
Work Group Report: COVID-19: Unmasking Telemedicine	58
COVID-19 Susceptibility in Bronchial Asthma	58
Trends in hospitalizations for asthma during the COVID-19 outbreak in Japan	57
Reduction of allergic rhinitis symptoms with face mask usage during the COVID-19 pandemic	57
The Pathogenesis of Chronic Spontaneous Urticaria: The Role of Infiltrating Cells	57
Comparative Study of Food Allergies in Children from China, India, and Russia: The EuroPrevall-INCO Surveys	54
Penicillin Allergy Delabeling: A Multidisciplinary Opportunity	53
Complications of switching from anti–IL-5 or anti–IL-5R to dupilumab in corticosteroid-dependent severe asthma	53
Digital Health Technology in Asthma: A Comprehensive Scoping Review	52
Impact of Allergic Rhinitis and Asthma on COVID-19 Infection, Hospitalization, and Mortality	52
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity	52
The Unexpected Risks of COVID-19 on Asthma Control in Children	51
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study	51
Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis	51
Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal Polyps	50
Cluster Analysis of Inflammatory Biomarker Expression in the International Severe Asthma Registry	49
Epidemiology of Chronic Rhinosinusitis: Prevalence and Risk Factors	49
The Beneficial Effect of Farm Milk Consumption on Asthma, Allergies, and Infections: From Meta-Analysis of Evidence to Clinical Trial	49
Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to 5 Years	49
Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: General Concepts	49
Prospective Assessment of Pediatrician-Diagnosed Food Protein–Induced Allergic Proctocolitis by Gross or Occult Blood	48
Different Measures of Diet Diversity During Infancy and the Association with Childhood Food Allergy in a UK Birth Cohort Study	48
The Prevalence of Subtypes of Type 2 Inflammation in an Unselected Population of Patients with Severe Asthma	48
Immunological Responses and Biomarkers for Allergen-Specific Immunotherapy Against Inhaled Allergens	48

Validation of the Angioedema Control Test (AECT)—A Patient-Reported Outcome Instrument for Assessing Angioedema Control	47
Primary Immunodeficiency Diseases and Bacillus Calmette-Guérin (BCG)-Vaccine–Derived Complications: A Systematic Review	47
Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection	46
Novel Approaches to Food Allergy Management During COVID-19 Inspire Long-Term Change	45
Clinical Characterization and Predictors of IOS-Defined Small-Airway Dysfunction in Asthma	45
Clinical, Immunological, and Genetic Features in Patients with Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) and IPEX-like Syndrome	45
Use and Interpretation of Acute and Baseline Tryptase in Perioperative Hypersensitivity and Anaphylaxis	44
An Approach to the Office-Based Practice of Food Oral Immunotherapy	43
Rhinovirus Infections and Their Roles in Asthma: Etiology and Exacerbations	43
Which Are the Optimal Criteria for the Diagnosis of Allergic Bronchopulmonary Aspergillosis? A Latent Class Analysis	43
Epinephrine in the Management of Anaphylaxis	42
Potential Severe Asthma Hidden in UK Primary Care	42
Urticaria and Angioedema Across the Ages	42
Dupilumab Improves Asthma Control and Lung Function in Patients with Insufficient Outcome During Previous Antibody Therapy	42
Earlier aggressive treatment to shorten the duration of eczema in infants resulted in fewer food allergies at 2 years of age	42
Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak	42
Prevalence and Burden of Chronic Cough in the United States	42
Effectiveness of myAirCoach: A mHealth Self-Management System in Asthma	42
Acute At Home Management of Anaphylaxis During the Covid-19 Pandemic	41
International Consensus on the Use of Genetics in the Management of Hereditary Angioedema	41
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study	41
Interactions Between Air Pollution and Pollen Season for Rhinitis Using Mobile Technology: A MASK-POLLAR Study	41
Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps	40
Diagnostic Delay in Patients with Eosinophilic Gastritis and/or Duodenitis: A Population-Based Study	40
Epidemiology of Nonesophageal Eosinophilic Gastrointestinal Diseases in Symptomatic Patients: A Systematic Review and Meta-Analysis	40
2020 NAEPP Guidelines Update and GINA 2021—Asthma Care Differences, Overlap, and Challenges	40
Current and Future Treatments of Rhinitis and Sinusitis	40
First Real-World Effectiveness Analysis of Preschool Peanut Oral Immunotherapy	39
Autoimmune Chronic Spontaneous Urticaria Detection with IgG Anti-TPO and Total IgE	39
Geospatial Analysis of Social Determinants of Health Identifies Neighborhood Hot Spots Associated With Pediatric Intensive Care Use for Life-Threatening Asthma	39
Small Airway Dysfunction Links Asthma Severity with Physical Activity and Symptom Control	39
Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19	39
Impact of the COVID-19 pandemic in children with allergic asthma	38
The Impact of Patient Self-Monitoring Via Electronic Medication Monitor and Mobile App Plus Remote Clinician Feedback on Adherence to Inhaled Corticosteroids: A Randomized Controlled Trial	38
Hidden Dangers: Recognizing Excipients as Potential Causes of Drug and Vaccine Hypersensitivity Reactions	38
“Idiopathic Eosinophilic Vasculitis”: Another Side of Hypereosinophilic Syndrome? A Comprehensive Analysis of 117 Cases in Asthma-Free Patients	38
Age-Related Differences in Immunological Responses to SARS-CoV-2	37
Community Use of Epinephrine for the Treatment of Anaphylaxis: A Review and Meta-Analysis	37
The Genetic Basis and Clinical Impact of Hereditary Alpha-Tryptasemia	37
The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma	37
Anaphylaxis to PEGylated liposomal echocardiogram contrast in a patient with IgE-mediated macrogol allergy	36
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study	36
COVID-19 Vaccination in Patients with Reported Allergic Reactions: Updated Evidence and Suggested Approach	36
Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics: A National Institute of Allergy and Infectious Diseases Workshop	36
Weathering the Cytokine Storm in Susceptible Patients with Severe SARS-CoV-2 Infection	36
SARS-CoV-2 Vaccines: Where Are We Now?	35
A Slice of Food Protein–Induced Enterocolitis Syndrome (FPIES): Insights from 441 Children with FPIES as Provided by Caregivers in the International FPIES Association	35
Penicillin Allergy Assessment in Pregnancy: Safety and Impact on Antibiotic Use	35
Prevalence and Characteristics of Shellfish Allergy in the Pediatric Population of the United States	35
Treatable Traits That Predict Health Status and Treatment Response in Airway Disease	34
Basophil Activation Test Reduces Oral Food Challenges to Nuts and Sesame	34
Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America	34
Innate and Adaptive Immunity: ILC2 and Th2 Cells in Upper and Lower Airway Allergic Diseases	34
Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series	34
A Practical Guide to Implementing SMART in Asthma Management	34
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User’s Guide for Daily Clinical Practice	34
Chronic Rhinosinusitis With Nasal Polyps: Quality of Life in the Biologics Era	34
COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab	34
Burden of Specialist-Diagnosed Chronic Cough in Adults	33
Asthma and Three Colinear Comorbidities: Obesity, OSA, and GERD	33
Risk Factors and Characteristics of Biphasic Anaphylaxis	33
The Expanding Spectrum of Mutations in Hereditary Angioedema	32
Endophenotyping Oxaliplatin Hypersensitivity: Personalizing Desensitization to the Atypical Platin	32
Persistent Viral Presence Determines the Clinical Course of the Disease in COVID-19	32
Long-term follow-up and treatment outcomes of conjunctivitis during dupilumab treatment in patients with moderate-to-severe atopic dermatitis	32
Direct Challenges to Penicillin-Based Antibiotics in the Inpatient Setting	32
Trajectory Analyses of Adherence Patterns in a Real-Life Moderate to Severe Asthma Population	32
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review	31
Appraisal of the Real-World Effectiveness of Biologic Therapies in Aspirin-Exacerbated Respiratory Disease	31
Asthma Disease Status, COPD, and COVID-19 Severity in a Large Multiethnic Population	31
The Relationship of Asthma Biologics to Remission for Asthma	31
Improvements in Quality of Life in Children Following Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in the PEPITES and PEOPLE Studies	31
Sleep Disturbances and Atopic Dermatitis: Relationships, Methods for Assessment, and Therapies	31
Pragmatic Clinical Perspective on Biologics for Severe Refractory Type 2 Asthma	31
FEF25-75% Is a More Sensitive Measure Reflecting Airway Dysfunction in Patients with Asthma: A Comparison Study Using FEF25-75% and FEV1%	31
Serum Eosinophil-Derived Neurotoxin Better Reflect Asthma Control Status Than Blood Eosinophil Counts	30
Childhood Origins of Adult Lung Disease as Opportunities for Prevention	30
Allergens and Adjuvants in Allergen Immunotherapy for Immune Activation, Tolerance, and Resilience	30
Dupilumab Improves Asthma and Sinonasal Outcomes in Adults with Moderate to Severe Atopic Dermatitis	30
Alopecia Areata Is Associated with Atopic Diathesis: Results from a Population-Based Study of 51,561 Patients	30

Effect of COVID-19 on asthma exacerbation	30
Risk of Psychiatric Adverse Events Among Montelukast Users	30
Systematic Assessment of Difficult-to-Treat Asthma: Principles and Perspectives	30
Pediatric asthma exacerbations during the COVID-19 pandemic: Absence of the typical fall seasonal spike in Washington, DC	30
Adverse Reactions Associated with Penicillins, Carbapenems, Monobactams, and Clindamycin: A Retrospective Population-based Study	29
Efficacy and Safety of Ragweed SLIT-Tablet in Children with Allergic Rhinoconjunctivitis in a Randomized, Placebo-Controlled Trial	29
Halting the March: Primary Prevention of Atopic Dermatitis and Food Allergies	29
Comparison of Nonesophageal Eosinophilic Gastrointestinal Disorders with Eosinophilic Esophagitis: A Nationwide Survey	29
Translating Evidence to Optimize Patient Care Using GRADE	29
Elevated Atopic Comorbidity in Patients with Food Protein–Induced Enterocolitis	29
A Phased Approach to Resuming Suspended Allergy/Immunology Clinical Services	29
Biphasic Reactions in Emergency Department Anaphylaxis Patients: A Prospective Cohort Study	29
Targeting Downstream Type 2 Cytokines or Upstream Epithelial Alarmins for Severe Asthma	29
Comparison of Different Biologics for Treating Chronic Rhinosinusitis With Nasal Polyps: A Network Analysis	29
Clinical and Serological Characterization of the α-Gal Syndrome—Importance of Atopy for Symptom Severity in a European Cohort	28
A Randomized, Open-Label Trial of Hen's Egg Oral Immunotherapy: Efficacy and Humoral Immune Responses in 50 Children	28
Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results	28
Chronic Respiratory Diseases and the Outcomes of COVID-19: A Nationwide Retrospective Cohort Study of 39,420 Cases	28
COVID-19 affecting hereditary angioedema patients with and without C1 inhibitor deficiency	28
Add-On Omalizumab for Inadequately Controlled Severe Pollinosis Despite Standard-of-Care: A Randomized Study	28
Lower Use of Biologics for the Treatment of Asthma in Publicly Insured Individuals	28
Bringing the Next Generation of Food Allergy Diagnostics Into the Clinic	28
Low Frequency of IgE-Mediated Food Hypersensitivity in Mastocytosis	28
Advancing Food Allergy Through Epidemiology: Understanding and Addressing Disparities in Food Allergy Management and Outcomes	28
Managing Food Allergy When the Patient Is Not Highly Allergic	28
Benralizumab Completely Depletes Gastrointestinal Tissue Eosinophils and Improves Symptoms in Eosinophilic Gastrointestinal Disease	28
New Perspectives on Difficult Asthma; Sex and Age of Asthma-Onset Based Phenotypes	28
Effective Management of Severe Asthma with Biologic Medications in Adult Patients: A Literature Review and International Expert Opinion	28
Usage Patterns of Short-Acting β2-Agonists and Inhaled Corticosteroids in Asthma: A Targeted Literature Review	27
Ascertainment Bias in Anaphylaxis Safety Data of COVID-19 Vaccines	27
Disconnect between effects of mepolizumab on severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps	27
Establishing Amoxicillin Allergy in Children Through Direct Graded Oral Challenge (GOC): Evaluating Risk Factors for Positive Challenges, Safety, and Risk of Cross-Reactivity to Cephalosporines	27
Risk Factors for Hen's Egg Allergy in Europe: EuroPrevall Birth Cohort	27
Diagnosis of Sesame Allergy: Analysis of Current Practice and Exploration of Sesame Component Ses i 1	27
Disease-Modifying Effect of Japanese Cedar Pollen Sublingual Immunotherapy Tablets	27
Advances in IgE Testing for Diagnosis of Allergic Disease	27
COVID-19 infection in 10 common variable immunodeficiency patients in New York City	27
AAAAI Work Group Report: Trends in Oral Food Challenge Practices Among Allergists in the United States	27
Telemedical Asthma Education and Health Care Outcomes for School-Age Children: A Systematic Review	27
The Allergen: Sources, Extracts, and Molecules for Diagnosis of Allergic Disease	27
Patient Satisfaction with In-Person, Video, and Telephone Allergy/Immunology Evaluations During the COVID-19 Pandemic	27
Personalized Treatment of Asthma: The Importance of Sex and Gender Differences	27
Collagen—An Important Fish Allergen for Improved Diagnosis	26
Importance of Adequate Diagnostic Workup for Correct Diagnosis of Advanced Systemic Mastocytosis	26
Rhinitis Phenotypes	26
Estimating COVID-19 Infection and Severity Risks in Patients with Chronic Rhinosinusitis: A Korean Nationwide Cohort Study	26
A Cost-Effectiveness Evaluation of Hospitalizations, Fatalities, and Economic Outcomes Associated with Universal Versus Anaphylaxis Risk-Stratified COVID-19 Vaccination Strategies	26
Oral Corticosteroids and Risk of Preterm Birth in the California Medicaid Program	26
The Accuracy of Diagnostic Testing in Determining Tree Nut Allergy: A Systematic Review	26
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)	26
Systematic Assessment for Difficult and Severe Asthma Improves Outcomes and Halves Oral Corticosteroid Burden Independent of Monoclonal Biologic Use	26
A Systematic Review of the Effect of Physical Activity on Asthma Outcomes	26
Wheat Anaphylaxis in Adults Differs from Reactions to Other Types of Food	26
A Cost-Effectiveness Analysis of Epinephrine Autoinjector Risk Stratification for Patients with Food Allergy—One Epinephrine Autoinjector or Two?	26
Disparities in Asthma and Allergy Care: What Can We Do?	26
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium	26
Egg Allergy in US Children	26
The COVID-19 Pandemic in 2021: Avoiding Overdiagnosis of Anaphylaxis Risk While Safely Vaccinating the World	26
Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2)	26
Longitudinal Impact of Sputum Inflammatory Phenotypes on Small Airway Dysfunction and Disease Outcomes in Asthma	26
Effects of Aerobic Training Versus Breathing Exercises on Asthma Control: A Randomized Trial	25
Community Private Practice Clinical Experience with Peanut Oral Immunotherapy	25
Hypogammaglobulinemia After Chimeric Antigen Receptor (CAR) T-Cell Therapy: Characteristics, Management, and Future Directions	25
Food Insecure and Allergic in a Pandemic: A Vulnerable Population	25
The Adoption and Implementation of Digital Health Care in the Post–COVID-19 Era	25
A Streamlined Approach to Optimize Perioperative Antibiotic Prophylaxis in the Setting of Penicillin Allergy Labels	25
Allergic symptoms after mRNA COVID-19 vaccination and risk of incomplete vaccination	25
Quantification of Glucocorticoid-Associated Morbidity in Severe Asthma Using the Glucocorticoid Toxicity Index	25
Ten Rules for Implementation of a Telemedicine Program to Care for Patients with Asthma	25
Research Priorities in Pediatric Asthma: Results of a Global Survey of Multiple Stakeholder Groups by the Pediatric Asthma in Real Life (PeARL) Think Tank	25
How to Assess Effectiveness of Biologics for Asthma and What Steps to Take When There Is Not Benefit	25
Development of the Asthma Impairment and Risk Questionnaire (AIRQ): A Composite Control Measure	25
African American Children Are More Likely to Be Allergic to Shellfish and Finfish: Findings from FORWARD, a Multisite Cohort Study	24
Efficacy of House Dust Mite Sublingual Immunotherapy in Patients with Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial	24
Controversies in Allergy: Chemotherapy Reactions, Desensitize, or Delabel?	24
Personalized Medication Adherence Management in Asthma and Chronic Obstructive Pulmonary Disease: A Review of Effective Interventions and Development of a Practical Adherence Toolkit	24
Oral amoxicillin challenges in low-risk children during a pediatric emergency department visit	24
Patient Characteristics and Risk Factors for Home Epinephrine-Treated Reactions During Oral Immunotherapy for Food Allergy	24
Effect of Inhaled Corticosteroids on Exacerbation of Asthma-COPD Overlap According to Different Diagnostic Criteria	24
Balancing Cancer Immunotherapy Efficacy and Toxicity	24
The Role of In Vivo and Ex Vivo Diagnostic Tools in Severe Delayed Immune-Mediated Adverse Antibiotic Drug Reactions	24
Food-Induced Anaphylaxis in Infants: Can New Evidence Assist with Implementation of Food Allergy Prevention and Treatment?	24
Benralizumab for severe DRESS in two COVID-19 patients	24
Recent dramatic increase in patients with food protein–induced enterocolitis syndrome (FPIES) provoked by hen’s egg in Japan	24
Glycated Hemoglobin A1c, Lung Function, and Hospitalizations Among Adults with Asthma	24
Peanut-induced food protein–induced enterocolitis syndrome (FPIES) in infants with early peanut introduction	24
Efficacy of Subcutaneous and Sublingual Immunotherapy for House Dust Mite Allergy: A Network Meta-Analysis–Based Comparison	24
Vaccine Hesitancy: Drivers and How the Allergy Community Can Help	24
Allergy Evaluation of Hypersensitivity to Platinum Salts and Taxanes: A Six-Year Experience	24
Anaphylaxis to sugammadex-rocuronium inclusion complex: An IgE-mediated reaction due to allergenic changes at the sugammadex primary rim	24
“COVID Arm”: Very delayed large injection site reactions to mRNA COVID-19 vaccines	23
Food Insecurity in the Food Allergic Population: A Work Group Report of the AAAAI Adverse Reactions to Foods Committee	23
Cell-Based Functional IgE Assays Are Superior to Conventional Allergy Tests for Shrimp Allergy Diagnosis	23
Delabeling Delayed Drug Hypersensitivity: How Far Can You Safely Go?	23
Synchronous Telemedicine in Allergy: Lessons Learned and Transformation of Care During the COVID-19 Pandemic	23